C.E Pharma

Sint-Jans-Molenbeek ·KBO/BCE: BE 0793.409.817

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	nothing on record	not filed	-
31-12-2024	31-07-2025	31-08-2025	31 d late	2025-00454359
31-12-2023	31-07-2024	07-10-2024	68 d late	2024-00496658

Line item	Code	2023
Balance sheet, Assets
TOTAL ASSETS	20/58	€349k
Fixed assets	21/28	€242k
Intangible fixed assets	21	€121k
Tangible fixed assets	22/27	€121k
Financial fixed assets	28	€111
Current assets	29/58	€107k
Stocks & contracts in progress	3	€33k
Amounts receivable within one year	40/41	€24k
Investments	50/53	€50k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€349k
Equity	10/15	€-6k
Contributions / capital	10/11	€10k
Accumulated profits (losses)	14	€-16k
Amounts payable	17/49	€355k
Amounts payable after one year	17	€247k
Amounts payable within one year	42/48	€109k
Trade debts payable within one year	44	€57k
Income statement
Gross operating margin	9900	€82k
Operating result	9901	€-3k
Financial income	75	€7
Financial charges	65	€13k
Result before taxes	9903	€-16k
Income taxes	67/77	€2
Net result for the period	9904	€-16k
Result to be appropriated	9905	€-16k

Summary